The accurate measurement of multiphase flows of oil/water/gas is a critical element of oil exploration and production. Thus, over the last three decades; the development and deployment of in-line multiphase flow metering systems has been a major focus worldwide. Accurate measurement of multiphase flow in the oil and gas industry is difficult because there is a wide range of flow regimes and multiphase meters do not generally perform well under the intermittent slug flow conditions which commonly occur in oil production. This thesis investigates the use of Doppler and cross-correlation ultrasonic measurements made in different high gas void fraction flow, partially separated liquid and gas flows, and homogeneous flow and raw slug flow, to assess the accuracy of measurement in these regimes. This approach has been tested on water/air flows in a 50mm diameter pipe facility. The system employs a partial gas/liquid separation and homogenisation using a T-Y junction configuration. A combination of ultrasonic measurement techniques was used to measure flow velocities and conductivity rings to measure the gas fraction. In the partially separated regime, ultrasonic cross-correlation and conductivity rings are used to measure the liquid flow-rate. In the homogeneous flow, a clamp-on ultrasonic Doppler meter is used to measure the homogeneous velocity and combined with conductivity ring measurements to provide measurement of the liquid and gas flow-rates. The slug flow regime measurements employ the raw Doppler shift data from the ultrasonic Doppler flowmeter, together with the slug flow closure equation and combined with gas fraction obtained by conductivity rings, to determine the liquid and gas flow-rates. Measurements were made with liquid velocities from 1.0m/s to 2.0m/s with gas void fractions up to 60%. Using these techniques the accuracies of the liquid flow-rate measurement in the partially separated, homogeneous and slug regimes were 10%, 10% and 15% respectively. The accuracy of the gas flow-rate in both the homogeneous and raw slug regimes was 10%. The method offers the possibility of further improvement in the accuracy by combining measurement from different regimes.

Microneedles have been developed as a minimally invasive alternative to painful hypodermic needles to deliver modern biotherapeutics. Previously, several in-vitro and in-vivo animal studies have been conducted to show that microneedles increase skin permeability to a wide range of molecules that cannot cross the skin using conventional transdermal patches due to the skin's stratum corneum barrier. However, only a limited number of studies have been performed to study microneedle-based drug delivery in human subjects. Therefore, the objective of this study was to perform the first-in-humans microneedle studies to: a) characterize skin repair responses to solid microneedle insertion to determine the extent of increased skin permeability coupled with predictions of pharmacokinetics of drug delivered through premeabilized skin, b) determine the effect of hollow microneedle-based infusion parameters on flow conductivity of skin and pain and thereby identify barriers to fluid flow into the skin from hollow microneedles, c) assess the safety and efficacy of systemic therapeutic effects through measurement of pharmacokinetic parameters, pain and irritation for microneedle-based insulin delivery in type 1 diabetes subjects, and d) assess the safety and efficacy of local therapeutic effects though delivery of lidocaine to the skin. Results showed for the first time that solid microneedle-treated skin reseals rapidly (< 2 h) in the absence of occlusion whereas occluded skin reseals slowly (3-40 h) depending on microneedle geometry as determined by skin impedance measurements. Increased microneedle length, number, and cross-sectional area led to slower recovery kinetics in the presence of occlusion. This thesis also demonstrated that the flow conductivity of skin decreased as fluid was infused to the dermis through hollow microneedles due to the dense structure of the dermis. Microneedle retraction, low flow rates, and the addition of hyaluronidase helped increase flow conductivity. Microneedles were able to deliver 800 µl of saline to the dermis without causing significant pain. Further, microneedle-based insulin delivery in type 1 diabetes subjects revealed that microneedles provided faster pharmacokinetics and improved glycaemic control than conventional subcutaneous catheters. Lastly, microneedle-based lidocaine injection demonstrated that microneedles were less painful, as effective, and more preferred than hypodermic needles in anesthetizing clinically relevant areas.